News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
As the Gates Foundation works to bring universities’ medical innovations to the developing world, student activists are taking up the fight as well.
In a policy statement to be announced this week, Universities Allied for Essential Medicines will push higher-ed institutions to include guarantees of generic access to low-income countries in their licensing agreements with pharmaceutical companies. The student group has chapters at 32 campuses, including Harvard.
The consensus statement has drawn a slew of high-profile signatories, including four Nobel laureates and a sitting justice on the South African Supreme Court of Appeal.
“For too long, life-saving medical tools that are the fruits of university-led discovery have been denied to poor people in poor countries,” said Paul Farmer, Harvard’s Presley professor of medical anthropology and one of the signatories, in a press release. “If our universities really are to be institutions for the public good, this must change.”
Harvard’s agreement with Medicine in Need inches the University closer toward at least two of the group’s recommendations: that universities forgo their royalties to bring about discounts in developing nations, and that they partner with third-party organizations to help with drug development and distribution.
Want to keep up with breaking news? Subscribe to our email newsletter.